1992
DOI: 10.1159/000108989
|View full text |Cite
|
Sign up to set email alerts
|

Glibenclamide Inhibits the Contractile Responses of Canine Middle Cerebral Artery to Eicosanoids and Oxyhemoglobin

Abstract: Glibenclamide is a sulfonylurea used in the management of diabetes mellitus but which is also known to have antagonist activity against the effects of some eicosanoids on smooth muscle. We have examined the action of glibenclamide against contractions of rings of canine middle cerebral artery by prostaglandins F, E2 and D2 and the thromboxane A2 analog U46619. All these responses were significantly attenuated by glibenclamide, while contractions to potassium chlori… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1998
1998
1998
1998

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Some K + channel inhibitors have actions other than channel inhibition. In particular, in the case of glibenclamide, inhibitory actions on responses produced by several kinds of prostanoids are also known (Cocks, King & Angus, 1990; Zhang, Stockbridge, Weir, Krueger & Cook, 1991; Zhang, Weir, Stockbridge, Doi & Cook, 1992). The slow hyperpolarization may be produced by prostanoids, since this potential was inhibited after blockade of the activity of cyclo‐oxygenase.…”
Section: Discussionmentioning
confidence: 99%
“…Some K + channel inhibitors have actions other than channel inhibition. In particular, in the case of glibenclamide, inhibitory actions on responses produced by several kinds of prostanoids are also known (Cocks, King & Angus, 1990; Zhang, Stockbridge, Weir, Krueger & Cook, 1991; Zhang, Weir, Stockbridge, Doi & Cook, 1992). The slow hyperpolarization may be produced by prostanoids, since this potential was inhibited after blockade of the activity of cyclo‐oxygenase.…”
Section: Discussionmentioning
confidence: 99%